₹55.5
▼ -2.5 -4.31%
As of 06 Nov 2026 · delayed
BSE Listed
Chandra Bhagat Pharma Limited (542934)
Volume: 2,000Avg Vol 1W: 4,200Avg Vol 1M: 6,86452W Range:₹29.7₹60.06
Key Ratios
Checked 2h agoMarket Cap—
Current Price₹55.5
Previous Close₹58
High / Low (52w)₹60.06 / ₹29.7
Volume2,000
Avg Vol (1W)4,200
Avg Vol (1M)6,864
Stock P/E—
Book Value—
Dividend Yield—
ROE—
ROA—
Revenue (TTM)—
Revenue Growth—
Profit Margin—
Total Debt—
Shares Outstanding—
Face Value—
EPS (TTM)—
P/B—
Debt / Equity0.59
50 DMA₹48.38
200 DMA₹46.09
Day change-4.31%
Price Chart
₹55.5▲ 38.72% · 1Y
2025-11-132026-11-06
20-day avg volume: 7K shares
Pros
- Company is almost debt-free.
- Revenue grew 30% YoY.
- Net profit is growing year over year.
Profit & Loss (Annual)
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹107 Cr | ₹94 Cr | ₹71 Cr | ₹96 Cr | ₹120 Cr | ₹233 Cr | ₹92 Cr | ₹120 Cr |
| EBITDA | ₹5 Cr | ₹3 Cr | ₹4 Cr | ₹4 Cr | ₹3 Cr | ₹4 Cr | ₹3 Cr | ₹6 Cr |
| Net Profit | ₹1 Cr | ₹0 Cr | ₹0 Cr | ₹1 Cr | ₹1 Cr | ₹2 Cr | ₹1 Cr | ₹3 Cr |
| EPS | 13.38 | 0.55 | 0.25 | 1.06 | 1.2 | 2.03 | 1.14 | 4.04 |
Balance Sheet
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | ₹83 Cr | ₹75 Cr | ₹72 Cr | ₹72 Cr | ₹61 Cr | ₹102 Cr | ₹102 Cr | ₹94 Cr |
| Total Liabilities | ₹68 Cr | ₹49 Cr | ₹46 Cr | ₹46 Cr | ₹33 Cr | ₹73 Cr | ₹72 Cr | ₹61 Cr |
| Equity | ₹14 Cr | ₹26 Cr | ₹26 Cr | ₹27 Cr | ₹27 Cr | ₹29 Cr | ₹30 Cr | ₹33 Cr |
| Total Debt | — | — | — | — | — | — | — | — |
Cash Flow
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Operating | ₹8 Cr | ₹13 Cr | ₹6 Cr | ₹7 Cr | ₹-5 Cr | ₹10 Cr |
| Investing | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹-2 Cr | ₹-1 Cr | ₹0 Cr |
| Financing | ₹-6 Cr | ₹-10 Cr | ₹-4 Cr | ₹-6 Cr | ₹2 Cr | ₹-6 Cr |
| Free Cash Flow | ₹8 Cr | ₹13 Cr | ₹6 Cr | ₹7 Cr | ₹-5 Cr | ₹10 Cr |
Shareholding
Promoter 73.02% Institutions 0% Public 26.98%
Efficiency & Working Capital
ROCE—
Interest Coverage3.1
Dividend Payout—
Debtor Days171 d
Inventory Days15 d
Payable Days100 d
Cash Conversion Cycle86 d
Working Capital Days186 d
Shareholding Details
As of 2026-09-30
Promoter73%
FII0%
DII0%
Institutions0%
Public27%
Promoter Pledge0%
No. of Shareholders290
Shareholding Pattern
Quarterly — figures in %. Latest 12 quarters.
| Period | Mar 2021 | Sept 2021 | Mar 2022 | Sept 2022 | Mar 2023 | Sept 2023 | Mar 2024 | Sept 2024 | Mar 2025 | Sept 2025 | Mar 2026 | Sept 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 71.8% | 71.8% | 70.1% | 69.1% | 68.2% | 68.7% | 68.8% | 69.3% | 71.2% | 72.2% | 73% | 73% |
| FIIs | 0% | 0% | 0% | 0.8% | 0.8% | 1.3% | 1.3% | 0.5% | 0.6% | 0.6% | 0% | 0% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0.9% | 0.9% | 0% | 0% | 0% | 0% | 0% |
| Public | 28.2% | 28.2% | 29.9% | 30.1% | 30.9% | 29.1% | 29% | 30.2% | 28.2% | 27.2% | 27% | 27% |
| Promoter Pledge | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| No. of Shareholders | 106 | 90 | 126 | 126 | 146 | 134 | 152 | 315 | 316 | 301 | 280 | 290 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202603 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Hemant Chandravadan Bhagat | Shareholding of Promoter and Promoter Group | 35.5% | 26,78,296 |
| Chitra Hemant Bhagat | Shareholding of Promoter and Promoter Group | 16.3% | 12,33,192 |
| Pranav Hemant Bhagat | Shareholding of Promoter and Promoter Group | 10.1% | 7,61,792 |
| Team Anamika Algo Limited | Public Shareholding | 5.8% | 4,35,000 |
| Prachi Pranav Bhagat | Shareholding of Promoter and Promoter Group | 5.4% | 4,03,600 |
| Hemant C Bhagat Huf | Shareholding of Promoter and Promoter Group | 2% | 1,48,576 |
| Prashant A Thakkar Huf | Public Shareholding | 1.8% | 1,35,000 |
| Mahesh C Bhagat | Shareholding of Promoter and Promoter Group | 1.6% | 1,20,000 |
| Riddhi Abhinav Chheda | Public Shareholding | 1.6% | 1,18,000 |
| Multiply Finvest Private Limited | Public Shareholding | 1.1% | 86,000 |
| First Rate Investments Private Limited | Public Shareholding | 1.1% | 85,000 |
| Jay Hemant Bhagat | Shareholding of Promoter and Promoter Group | 1.1% | 83,600 |
| Khyati Pradeep Joshi | Public Shareholding | 1.1% | 79,000 |
| Padmaben Chandravadan Bhagat | Shareholding of Promoter and Promoter Group | 0.5% | 40,000 |
| Naynaben Chandravadan Bhagat | Shareholding of Promoter and Promoter Group | 0.4% | 32,000 |
| Lopa Mahesh Bhagat | Shareholding of Promoter and Promoter Group | 0.1% | 8,000 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| Hemant C Bhagat | Chairman / Executive Director / M D / Promoter | 2026 |
| Pranav H Bhagat | WTD & Executive Director | 2026 |
| Prachi Pranav Bhagat | Executive Director & CFO | 2026 |
| Ravindra Gajanan Awati | Independent Non Exe. Director | 2026 |
| Abha Praveen Doshi | Independent Non Exe. Director | 2026 |
| Rajni Dawani | Company Sec. & Compli. Officer | 2026 |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2026 | ₹10 | 9 | 8 | 8 |
Corporate Actions
| Type | Date | Value | Remark |
|---|---|---|---|
| forthcoming | 2026-08-05 | Board Meetings | — |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2026 | 0 | 0 | 0 | 24 | 0 | 24 |
| 2026 | 0 | 0 | 0 | 23 | 0 | 24 |
| 2026 | 0 | 0 | 0 | 0 | 0 | 1 |
Insider / Designated-Person Trades
1 recent disclosure(s)
Prachi Pranav BhagatAcquisition · 62,000
Substantial Acquisitions (SAST)
3 disclosure(s)
Allotment22/10/2026 · —
Allotment Of Warrants On Preferential Basis22/10/2026 · 50,00,000
Allotment22/10/2026 · —
Company Information
🌐 www.cbcpharma.com ↗
📍 323-F Bhagat Bhuvan, Dr Ambedkar Road Matunga (E), Mumbai, Maharashtra, 400019
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search
